Atopic dermatitis differential diagnosis: Difference between revisions

	Xyz Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Xyz from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Atopic dermatitis differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Atopic dermatitis differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Atopic dermatitis differential diagnosis
CDC on Atopic dermatitis differential diagnosis
Atopic dermatitis differential diagnosis in the news
Blogs on Atopic dermatitis differential diagnosis
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Atopic dermatitis differential diagnosis

	Atopic dermatitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Atopic dermatitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography or Ultrasound
CT Scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Atopic dermatitis differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Atopic dermatitis differential diagnosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Atopic dermatitis differential diagnosis
CDC on Atopic dermatitis differential diagnosis
Atopic dermatitis differential diagnosis in the news
Blogs onAtopic dermatitis differential diagnosis
Directions to Hospitals Treating Atopic dermatitis
Risk calculators and risk factors forAtopic dermatitis differential diagnosis

VisualWikitext

Revision as of 16:12, 11 October 2018

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].

Differentiating [Disease name] from other Diseases

- Seborrhoeic dermatitis
  - onset during the 1st days or weeks of life, absence of pruritus, and presence of greasy scaling on a yellow-red base
  - Involvement of the top of the scalp (cradle cap), axilla, and diaper area makes it more likely the patient has seborrheic dermatitis, vs excoriated dermatitis involving the extensor surfaces, face, and trunk favour AE.
- Sarcoptes scabiei
  - highly pruritic, erythematous papular lesions. In most cases, the typical burrows can be found on the flexor wrists, finger webs and genitalia. Similar symptoms in other family members

							Symptoms						Physical examination					Lab Findings
Category	Diseases	Etiology	Inherited	Acquired	Demography	History	Clinical manifestations											Para-clinical findings							Gold standard	Additional findings
							Symptoms						Physical examination					Para-clinical findings
							Appearance				Itching	Bleeding	Fever	BP	Tenderness	Nail pitting	Other	CBC			ESR/CRP	Electrolytes	BUN/Cr	LFT
							Single/ Multiple	Rash	Involved areas	Pustule	Itching	Bleeding	Fever	BP	Tenderness		Other	WBC	Hb	Plt	ESR/CRP	Electrolytes	BUN/Cr	LFT
Skin disorders	Allergic contact dermatitis
	Irritant contact dermatitis
	Seborrheic dermatitis
	Psoriasis
	Lichen simplex chronicus
	Ichthyosis vulgaris
	Nummular Dermatitis
	Netherton syndrome
	Dubowitz syndrome
	Erythrokeratodermia variabilis
Infection	Dermatophytes
	Candida
	Herpes simplex
	Staphylococcus aureus
	Molluscum Contagiosum
	Scabies
	HIV
Immunologic disorders	Dermatitis herpetiformis
	Pemphigus foliaceus
	Graft-versus-host disease
	Dermatomyositis
Immune deficiency	Wiskott-Aldrich syndrome
	Hyper-IgE syndrome
	DiGeorge syndrome
	Severe combined immunodeficiency (SCID)
	Ataxia telangiectasia
Metabolic Diseases	Phenylketonuria
	Tyrosinemia
	Histidinemia
	Multiple carboxylase deficiency
Nutritional deficiencies	Zinc deficiency
	Niacin (B3) deficiency
	Pyridoxine (B6) deficiency
	Biotin (B7) deficiency
Malignancy	Mycosis fungoides
Malignancy	Histiocytosis X
Medications	Infliximab

References

Template:WikiDoc Sources

@@ Line 12: / Line 12: @@
 ==Differentiating [Disease name] from other Diseases==
-On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].
-* '''Chronic inflammatory skin diseases'''
-** Contact (allergic, irritant)
 ** Seborrhoeic dermatitis
 *** onset during the 1st days or weeks of life, absence of pruritus, and presence of greasy scaling on a yellow-red base
 *** Involvement of the top of the scalp (cradle cap), axilla, and diaper area makes it more likely the patient has '''seborrheic dermatitis''', vs excoriated dermatitis involving the extensor surfaces, face, and trunk favour '''AE.'''
-** Psoriasis
-** Lichen simplex chronicus
-* '''Infectious agents'''
-** Candida
-** Dermatophytes
-** Herpes simplex
-** Staphylococcus aureus
 ** Sarcoptes scabiei
 *** highly pruritic, erythematous papular lesions. In most cases, the typical burrows can be found on the flexor wrists, finger webs and genitalia. Similar symptoms in other family members
-** HIV-associated dermatitis
-* '''Immunologic disorders'''
-** Dermatitis herpetiformis
-** Pemphigus foliaceus
-** Graft-versus-host disease
-** Dermatomyositis
-* '''Malignant Diseases'''
-** Cutaneous T-cell lymphoma (mycosis fungoides, S´ezary syndrome)
-** Histiocytosis X (Letterer-Siwe disease)
-* '''Congenital disorders'''
-** Netherton’s syndrome
-** Dubowitz syndrome
-** Erythrokeratodermia variabilis
-* '''Immunodeficiencies'''
-** Wiskott-Aldrich syndrome (immunodeficiency with thrombocytopenia and eczema)
-** Thymic hypoplasia (DiGeorge syndrome)
-** Hyper-IgE syndrome
-** Severe combined immunodeficiency (SCID)
-** Ataxia telangiectasia
-* '''Metabolic Diseases'''
-** Phenylketonuria
-** Tyrosinemia
-** Histidinemia
-** Zinc deficiency
-** Pyridoxine (vitamin B6) and niacin deficiency
-** Multiple carboxylase deficiency
-* '''Nonallergic reaction to medication'''
-** Infliximab
 {|
 |- style="background: #4479BA; color: #FFFFFF; text-align: center;"
-!
+! rowspan="5" |Category
-! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
+! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
-|Etiology
+| rowspan="5" |Etiology
-|Congenital
+| rowspan="5" |Inherited
-|Acquired
+| rowspan="5" |Acquired
-|Demography
+| rowspan="5" |Demography
-|History
+| rowspan="5" |History
-| colspan="7" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
+| colspan="11" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Clinical manifestations'''
-! colspan="8" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
+! colspan="9" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings
-| colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
+| colspan="1" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Gold standard'''
-! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
+! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
 |-
-|
+| colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms'''
-|
+! colspan="5" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
-|
-|
-|
-|
-| colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Symptoms'''
-! colspan="4" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Physical examination
 |-
-!
+! colspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
-!
+! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
-!
+! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
-!
-!
-!
-! colspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
-! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
-! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology
 |-
-!
+! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance
-!
+! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Itching
-!
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bleeding
-!
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
-!
+! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
-!
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Tenderness
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Appearance
+!Nail pitting
-! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Itching
+! rowspan="2" |Other
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
-! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
-!Other
 ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |CBC
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP
-! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
+! rowspan="2" |Electrolytes
-!LFT
+! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |BUN/Cr
+! rowspan="2" |LFT
 |-
-!
+!Single/
-!
+Multiple
-!
+!Rash
-!
+!Involved areas
-!
+!Pustule
-!
-!
-!
-!
-!
-!
-!
-!
 !
 !WBC
 !Hb
 !Plt
-!
-!
-!
-!
-!
-!
-!
 |-
 | rowspan="10" |Skin disorders
@@ Line 139: / Line 70: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 144: / Line 78: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 149: / Line 84: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 | style="background: #F5F5F5; padding: 5px;" |
 |
@@ Line 163: / Line 99: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 168: / Line 107: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 173: / Line 113: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 | style="background: #F5F5F5; padding: 5px;" |
 |
@@ Line 187: / Line 128: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 192: / Line 136: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 197: / Line 142: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 | style="background: #F5F5F5; padding: 5px;" |
 |
@@ Line 211: / Line 157: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 216: / Line 165: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 221: / Line 171: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 | style="background: #F5F5F5; padding: 5px;" |
 |
@@ Line 229: / Line 180: @@
 |-
 |Lichen simplex chronicus
+|
+|
+|
+|
+|
 |
 |
@@ Line 253: / Line 209: @@
 |-
 |'''Ichthyosis vulgaris'''
+|
+|
+|
+|
+|
 |
 |
@@ Line 277: / Line 238: @@
 |-
 |'''Nummular Dermatitis'''
+|
+|
+|
+|
+|
 |
 |
@@ Line 301: / Line 267: @@
 |-
 |Netherton syndrome
+|
+|
+|
+|
+|
 |
 |
@@ Line 325: / Line 296: @@
 |-
 |Dubowitz syndrome
+|
+|
+|
+|
+|
 |
 |
@@ Line 349: / Line 325: @@
 |-
 |Erythrokeratodermia variabilis
+|
+|
+|
+|
+|
 |
 |
@@ Line 372: / Line 353: @@
 |
 |-
-| rowspan="6" |Infection
+| rowspan="7" |Infection
 | style="background: #DCDCDC; padding: 5px; text-align: center;" |Dermatophytes
 |
@@ Line 380: / Line 361: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 385: / Line 369: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 390: / Line 375: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 | style="background: #F5F5F5; padding: 5px;" |
 |
@@ Line 398: / Line 384: @@
 |-
 |Candida
+|
+|
+|
+|
+|
 |
 |
@@ Line 422: / Line 413: @@
 |-
 |Herpes simplex
+|
+|
+|
+|
+|
 |
 |
@@ Line 446: / Line 442: @@
 |-
 |Staphylococcus aureus
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|-
+|Molluscum Contagiosum
+|
+|
+|
+|
+|
 |
 |
@@ Line 470: / Line 500: @@
 |-
 |'''Scabies'''
+|
+|
+|
+|
+|
 |
 |
@@ Line 494: / Line 529: @@
 |-
 |HIV
+|
+|
+|
+|
+|
 |
 |
@@ Line 519: / Line 559: @@
 | rowspan="4" |Immunologic disorders
 |Dermatitis herpetiformis
+|
+|
+|
+|
+|
 |
 |
@@ Line 543: / Line 588: @@
 |-
 |Pemphigus foliaceus
+|
+|
+|
+|
+|
 |
 |
@@ Line 567: / Line 617: @@
 |-
 |Graft-versus-host disease
+|
+|
+|
+|
+|
 |
 |
@@ Line 591: / Line 646: @@
 |-
 |Dermatomyositis
+|
+|
+|
+|
+|
 |
 |
@@ Line 622: / Line 682: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 627: / Line 690: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 632: / Line 696: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 | style="background: #F5F5F5; padding: 5px;" |
 |
@@ Line 646: / Line 711: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 651: / Line 719: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 656: / Line 725: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 | style="background: #F5F5F5; padding: 5px;" |
 |
@@ Line 664: / Line 734: @@
 |-
 |DiGeorge syndrome
+|
+|
+|
+|
+|
 |
 |
@@ Line 688: / Line 763: @@
 |-
 |Severe combined immunodeficiency (SCID)
+|
+|
+|
+|
+|
 |
 |
@@ Line 712: / Line 792: @@
 |-
 |Ataxia telangiectasia
+|
+|
+|
+|
+|
 |
 |
@@ Line 737: / Line 822: @@
 | rowspan="4" |'''Metabolic Diseases'''
 |Phenylketonuria
+|
+|
+|
+|
+|
 |
 |
@@ Line 761: / Line 851: @@
 |-
 |Tyrosinemia
+|
+|
+|
+|
+|
 |
 |
@@ Line 785: / Line 880: @@
 |-
 |Histidinemia
+|
+|
+|
+|
+|
 |
 |
@@ Line 809: / Line 909: @@
 |-
 |Multiple carboxylase deficiency
+|
+|
+|
+|
+|
 |
 |
@@ Line 840: / Line 945: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 845: / Line 953: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 850: / Line 959: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 | style="background: #F5F5F5; padding: 5px;" |
 |
@@ Line 857: / Line 967: @@
 | style="background: #F5F5F5; padding: 5px;" |
 |-
-|Pyridoxine deficiency
+|Niacin (B3) deficiency
+|
+|
+|
+|
+|
 |
 |
@@ Line 881: / Line 996: @@
 |
 |-
-|Niacin deficiency
+|Pyridoxine (B6) deficiency
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|
+|-
+|
+|Biotin (B7) deficiency
+|
+|
+|
+|
+|
 |
 |
@@ Line 913: / Line 1,063: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
+|
+|
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 918: / Line 1,071: @@
 | style="background: #F5F5F5; padding: 5px;" |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 |
 | style="background: #F5F5F5; padding: 5px;" |
@@ Line 923: / Line 1,077: @@
 |
 | style="background: #F5F5F5; padding: 5px;" |
+|
 | style="background: #F5F5F5; padding: 5px;" |
 |
@@ Line 931: / Line 1,086: @@
 |-
 |Histiocytosis X
+|
+|
+|
+|
+|
 |
 |
@@ Line 956: / Line 1,116: @@
 |Medications
 |Infliximab
+|
+|
+|
+|
+|
 |
 |

Atopic dermatitis differential diagnosis: Difference between revisions

Revision as of 16:12, 11 October 2018

Overview

Differentiating [Disease name] from other Diseases

References

Navigation menu